Ontogeny of the human central nervous system: What is happening when?

被引:410
作者
de Graaf-Peters, Victorine B. [1 ]
Hadders-Algra, Mijna [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Neurol Dev Neurol, NL-9713 GZ Groningen, Netherlands
关键词
brain development; human development; transient circuitries; preterm; stress;
D O I
10.1016/j.earlhumdev.2005.10.013
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
The present paper reviews current data on the structural development of the human nervous system. Focus is on the timing of ontogenetic events in the telencephalon. Neuronal proliferation and migration especially occur during the first half of gestation; the second half of gestation is the period of the existence of the functionally important transient structure 'subplate' and the major period of glial cell proliferation and programmed cell death. Axon and dendrite sprouting and synapse formation bloom during the last trimester of gestation and the first postnatal year. Major part of telencephalic myelination occurs during the first year after birth. Many developmental processes, such as myelination, synapse formation and synapse elimination continue throughout childhood and adolescence. Evidence is emerging that the peak of synapse elimination occurs between puberty and the onset of adulthood. Neurotransmitter systems are present from early foetal life onwards and their pre- and perinatat development is characterized by periods of transient overexpression. The tatter is for instance true for the acetytchotinergic, catecholaminergic and glutamate systems. Thus, the development of the human brain is characterized by a protracted, neatly orchestrated chain of specific ontogenetic events. The continuous changes of the nervous system have consequences for vulnerability to adverse conditions, for diagnostics and for physiotherapeutical intervention. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 123 条
[1]
Early experience alters brain function and structure [J].
Als, H ;
Duffy, FH ;
McAnulty, GB ;
Rivkin, MJ ;
Vajapeyam, S ;
Mulkern, RV ;
Warfield, SK ;
Huppi, PS ;
Butler, SC ;
Conneman, N ;
Fischer, C ;
Eichenwald, EC .
PEDIATRICS, 2004, 113 (04) :846-857
[2]
INDIVIDUALIZED DEVELOPMENTAL CARE FOR THE VERY-LOW-BIRTH-WEIGHT PRETERM INFANT - MEDICAL AND NEUROFUNCTIONAL EFFECTS [J].
ALS, H ;
LAWHON, G ;
DUFFY, FH ;
MCANULTY, GB ;
GIBESGROSSMAN, R ;
BLICKMAN, JG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (11) :853-858
[3]
ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1
[4]
[Anonymous], EFFECTIVENESS EARLY
[5]
[Anonymous], 1977, Clinics in Developmental Medicine
[6]
[Anonymous], NEURONAL ACTIVITY GR
[7]
Back SA, 2001, J NEUROSCI, V21, P1302
[8]
Barone P, 1996, J COMP NEUROL, V374, P1, DOI 10.1002/(SICI)1096-9861(19961007)374:1<1::AID-CNE1>3.0.CO
[9]
2-7
[10]
Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P774